Following the complete sequencing of the human and mouse genomes, the functional analysis of each of the twenty thousand or so proteincoding genes remains an important goal and a major technical challenge. Several genome-wide mutagenesis strategies have been applied in the mouse, including ethyl-nitrosourea (ENU) mutagenesis, transposon mutagenesis, gene trapping and gene targeting. Gene trapping in mouse embryonic stem (ES) cells 1, 2 has been the most productive so far, providing hundreds of thousands of random insertional mutations in more than half of the protein-coding genes in the mouse [3] [4] [5] . Notably, these ES cell resources can be archived indefinitely and are easily distributed to the scientific community for the purpose of generating knockout mice. However, gene-trap alleles cannot be precisely engineered and the strategy favours genes expressed in mouse ES cells.
Given the limitations of gene trapping, it is clear that the generation of a complete set of gene knockouts in the mouse will require the application of gene-targeting technology in ES cells [6] [7] [8] . Gene targeting can be used to engineer virtually any alteration in the mammalian genome by homologous recombination in mouse ES cells, from point mutations to large chromosomal rearrangements 9, 10 . Over the past 20 years, gene targeting has been used to elucidate the function of more than 5,000 mammalian genes. Scaling this technology to the remainder of the genome presents numerous technical challenges and requires the production of targeted ES cells on an unprecedented scale, beyond the scope of conventional methodologies.
The first targeting pipeline for ES cells was reported several years ago before the completion of the mouse genome sequence (Velocigene) 11 . Bacterial artificial chromosome (BAC)-based targeting vectors were constructed to replace the coding sequence of the target gene with a lacZ reporter and promoter-driven selection cassette. Oligonucleotides required for the construction of targeting vectors by recombineering were based on cDNA sequences surrounding the translation initiation and termination signals of each target gene, thus requiring no previous knowledge of the underlying genomic structure of the gene. In a single recombineering step, modified BAC clones were generated with high efficiency and used to target genes in ES cells. Correctly targeted events, which involved the deletion of up to 70-kilobases (kb) of genomic sequence, were identified using a novel high-throughput allelecounting assay. The deletion of large regions of genomic sequence, although effective for eliminating the function of the target gene, can have unintended consequences on the regulation of adjacent and distant transcriptional units 12, 13 . To support and accelerate progress towards the genetic analysis of all mammalian genes, large-scale knockout consortia were established in 2006 with the goal of generating a complete resource of reportertagged null mutations in C57BL/6 mouse ES cells 14 . C57BL/6 is one of the best characterized inbred strains, is the reference strain for the mouse genome sequence and breed well in the laboratory. Thus, the study of mutant alleles in a pure C57BL/6 genetic background is considered to be ideal for large-scale phenotyping efforts that will follow. Highly germline-competent ES cell lines from the C57BL/ 6N substrain of mice have been established for this project [15] [16] [17] . A common web portal providing information and access to the resource has been established 18 , with links to designated repositories for ordering vectors, ES cell clones and mice.
Here we describe a pipeline for the design and mass parallel construction of conditional targeting vectors by serial 96-well BAC recombineering and high-throughput gene targeting in C57BL/6 ES cells. Our pipeline is configured to create a number of useful resources en route to the generation of targeted ES cells (Supplementary Fig. 1 ). Ongoing large-scale production of targeted ES cell lines demonstrates rates of homologous recombination in C57BL/6 ES cells well above the historical average. Our pipeline forms the basis for the generation of thousands of lacZ-tagged conditional alleles for the European Conditional Mouse Mutatgenesis (EUCOMM) and the National Institutes of Health Knockout Mouse (KOMP) programs as part of the international knockout effort 14 .
Computer-assisted design of alleles
Conditional alleles permit the analysis of gene function in a tissuespecific or temporal manner during embryonic and postnatal development 10, 19 . Our conditional allele is based on the 'knockout-first' design 20 , a strategy that combines the advantages of both a reporter-tagged and a conditional mutation ( Fig. 1 and Supplementary Fig. 2 ). In contrast to standard conditional designs, the initial unmodified allele is predicted to generate a null allele through splicing to a lacZ trapping element contained in the targeting cassette. Our trapping cassettes include the mouse En2 splice acceptor and the SV40 polyadenylation sequences, signals that have proven to be highly effective in creating null alleles in mice 2, 21 . The knockout-first allele can be easily modified in ES cells or in crosses to transgenic FLP and cre mice. Conditional alleles are generated by removal of the gene-trap cassette by Flp recombinase, which reverts the mutation to wild type, leaving loxP sites on either side of a critical exon. Subsequent exposure to Cre deletes the critical exon to induce a frameshift mutation and trigger nonsense-mediated decay of the mutant transcript. Many cre transgenic strains are available for the study of gene function in specific tissues and developmental time points (see http://www.creline.org).
Typically, loxP sites are placed in introns of genes to avoid disrupting normal transcription, processing and translation of the target gene. The loxP and FRT sites are positioned to minimize possible interference with the splice sites of the critical exon. In some cases, the presence of the recombinase sites may perturb normal splicing patterns 22 . This caveat notwithstanding, knockout first alleles are very useful for proving the causality of gene disruptions and observed phenotypes. Reversion of the phenotype with Flp, or conversely, induction of the phenotype with Cre, rule out potential effects of secondary linked mutations that can arise in cultured ES cells 23 . Furthermore, removal of the FRT-flanked stop cassette is particularly useful for further studies of genes that present heterozygous lethal phenotypes.
The vector design process ideally begins with high-quality manual annotation of gene structures 24 . Manual annotation identifies and resolves errors in automated gene predictions and captures all known transcript variants from available messenger RNA evidence. However, manual annotation of genes is a time-consuming process and proved rate-limiting in our high-throughput pipeline. Although the accuracy of automated gene prediction is improving, vector designs for Ensembl gene structures must be approached with caution.
To assist in the design of conditional alleles, we developed a computational tool to identify oligonucleotide sequences (50-mers) suitable for recombineering. These sequences are used to insert a selection cassette and loxP site around the critical exon and to recover homologous sequence from the BAC required for gene targeting (Fig. 2a) . More generally, these computational tools can be applied to any other mammalian or non-mammalian genome for which the construction of large numbers of recombineered DNA constructs is desired. Each design is displayed on the genome browser ( Fig. 2b) and manually inspected to choose the optimal design. Valid designs are selected for the 59-most critical exon(s) that is common to all known transcript variants and disrupts at least 50% of the protein-coding sequence. Designs are rejected if the deleted region contains highly conserved intronic sequence as these elements are likely to correspond to regulatory elements and complicate the interpretation of the mutant phenotype in mice 12, 13 . Approximately 40% of protein-coding genes do not fit our design criteria, most commonly, small transcription units composed of one or two exons. Genes with alternative 59 end transcripts are also problematical. In some cases, it is not possible to remove a single exon or cluster of exons that disrupts all isoforms. These genes have been set aside for other partners within the international knockout consortium to generate standard lacZ-tagged deletion alleles using, for example, Velocigene technology 11 .
Construction of modular targeting vectors
For the generation of conditional gene-targeting vectors, we developed a strategy for high-throughput, serial, liquid BAC recombineering in 96-well format ( Fig. 3 ) similar to that reported for transgene production 25, 26 . We adopted a modular strategy for the construction of targeting vectors using recombineering to create Gateway-adapted intermediate vectors ( Fig. 4a ) that are later assembled into the final targeting construct through in vitro Gateway reactions (Fig. 4b ). For targeting in C57BL/ 6N ES cells 16 , we made use of indexed C57BL/6J BAC libraries 27 for the construction of targeting vectors.
The construction of Gateway-adapted intermediate targeting vectors from BACs involves three consecutive recombineering steps: insertion of an attR1/attR2 zeo-pheS Gateway element upstream of the critical exon ( Fig. 3b and Supplementary Fig. 3 ); insertion of a floxed kanR cassette downstream of a critical exon (Fig. 3c) ; and subcloning of the modified region of genomic DNA (8-10 kb) into a Gateway-adapted plasmid backbone by gap repair (Fig. 3d and Supplementary Fig. 3 ). Heterologous attR3/attR4 sites are included to enable switching of the plasmid backbone to introduce a negative selection cassette for positive-negative targeting in ES cells. The exquisite efficiency and nucleotide precision of Red operon-induced recombination in bacteria permitted the assembly of DNA constructs in 96-well format through three rounds of recombineering with an 80% overall efficiency (Supplementary Table 1 ). This efficiency of vector production readily accommodates the needs of the global mouse genetargeting projects that aim to knock out thousands of genes per year 14 .
Assembly of the final targeting constructs
Gateway technology has been successfully used for the construction of large-scale genomic resources 28, 29 . The use of Gateway technology minimizes the potential for deleterious mutations common to polymerase chain reaction (PCR)-based cloning methods. We developed a series of promoterless and promoter-driven selection cassettes flanked by attL1/attL2 sites ( Supplementary Fig. 4 ). To use positive-negative selection for gene targeting 30 , a plasmid backbone was constructed that contains attL3/attL4 Gateway elements and a diphtheria-toxin-Achain 31 (DTA) expression cassette. Final targeting constructs were 'knockout-first' allele (tm1a) contains an IRES:lacZ trapping cassette and a floxed promoter-driven neo cassette inserted into the intron of a gene, disrupting gene function. Flp converts the 'knockout-first' allele to a conditional allele (tm1c), restoring gene activity. Cre deletes the promoterdriven selection cassette and floxed exon of the tm1a allele to generate a lacZtagged allele (tm1b) or deletes the floxed exon of the tm1c allele to generate a frameshift mutation (tm1d), triggering nonsense mediated decay of the deleted transcript.
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vectors with different selectable markers can be readily constructed to knock out the second allele of genes for functional studies in homozygous ES cells. Finally, knock-ins of wild-type and mutant cDNAs provide an avenue for detailed structure-function studies or to explore human variation. Thus, a permanent library of intermediate targeting plasmids will permit the further exploitation of targeting technology in the future.
High-throughput ES cell production
To scale targeting experiments to high throughput, we optimized electroporation conditions for C57BL/6N ES cells 16 in multi-well cuvettes. Here we aimed to minimize the number of cells and amount of plasmid DNA required to obtain sufficient drug-resistant colonies for screening (Table 1) . After selection, expansion and freezing, most (65%) ES cell clones retained their ability to colonize the germ line of mice 16 . Homologous recombinants generated with targeting vectors are usually identified by Southern blotting. However, this method is not practical for large-scale screening. Long-range PCR (LR-PCR) is an alternative method 32 which is better-suited to high-throughput genotyping of ES cell clones. We developed a 384-well LR-PCR method to identify correctly targeted events (Fig. 5) . PCR fragments, amplified with gene-specific primers outside the homology arms in combination with primers in the targeting cassette, were sequence-verified. In general, LR-PCR was performed across the 39 homology arm. Because the targeted clones are genotyped at one end, non-homologous events within the opposite arm will occur in rare cases. Furthermore, mixed clones composed of targeted and non-targeted cells are not detected by our high-throughput genotyping protocol. For these reasons, further validation of targeted alleles using standard Southern blot assays is highly recommended before use.
Owing to frequent crossover events between the selectable marker and 39 loxP site, many of the targeted ES cell clones lose the 39 loxP site and cannot be converted to a conditional allele. To distinguish between these two alternative products of homologous recombination, LR-PCR products amplified from the 39 homology arm were sequenced with a primer at the loxP site. Where 39 LR-PCR failed to generate a product, LR-PCR was performed across the 59 homology arm (59 LR-PCR). For these cases, the retention of the 39 loxP site was confirmed by PCR between the cassette and 39 loxP site.
Gene targeting is highly efficient
High-throughput gene targeting depends on achieving high targeting efficiencies. For genes expressed in ES cells, a promoterless targeting strategy (referred to as 'targeted trapping') 33 has been shown to yield targeting efficiencies averaging above 50%. By design, promoterless vectors effectively suppress the recovery of random non-homologous events in the genome as only insertions in transcribed loci, in the correct orientation and reading frame, will confer drug resistance. We electroporated 1,285 different promoterless constructs and obtained targeted clones from nearly half of these constructs with an average targeting efficiency of 50% (Table 1 ). These data confirm and extend the results of ref. 33 , demonstrating that targeted trapping is a highly efficient method for genes expressed in ES cells.
Only half of the promoterless targeting vectors were effective in producing targeted clones. Electroporation of these vectors produced variable numbers of drug-resistant colonies. In general, high colony numbers were predictive of successful targeting experiments, whereas low colony numbers usually indicated a failure to target the locus (Supplementary Table 2 ). The success or failure of a construct correlated with the number of clones with gene-trap events in the International Gene Trap Consortium database (Supplementary Table 3 ). Thus, genetrapping data serve as a useful guide to identify the subset of genes that are amenable to a promoterless targeting strategy 34 . Correlation with classes of gene was also observed. For instance, targeted trapping was less effective with secreted proteins compared to non-secreted proteins, indicating that our cassette designed for trapping secreted proteins (pL1L2_ST, see Supplementary Fig. 4 ) 35 is not optimal for this class of gene 36 . Given that only half of all genes are expressed at a sufficient level in ES cells to support a targeted trapping strategy, we switched to using a promoter-driven cassette for positive selection for non-expressed genes combined with negative DTA selection to select against random insertions. We electroporated different positive-negative targeting cassettes and from the analysis of approximately 30 ES cell clones per unique construct, we recovered targeted events for 80% of genes with an average targeting efficiency of 35% (Table 1 ; for a complete list of targeted genes see Supplementary Data). A combination of factors probably contribute to our high targeting efficiencies, including the use of isogenic DNA, relatively long recombineered homology arms and DTA negative selection.
Gene targeting is dependent on both the length and the extent of homology between the targeting vector and the target locus [37] [38] [39] . Our vectors typically contain 10 kb of homology to the endogenous locus and originate from a C57BL/6J BAC library. Although the ES cells are derived from the C57BL/6N sub-strain, the Jackson (J) and NIH (N) substrains of C57BL/6 are very closely related 16 , thus our targeting vectors will have identical sequence with the ES cell genome in the great majority of cases. Negative selection was introduced to improve targeting efficiencies 30, 31 . Overall we observed a threefold enrichment of targeted clones with DTA counter-selection, consistent with previous observations 30, 31, 40 (Table 1) . In a high-throughput pipeline, projects inevitably fail at one or more steps and overall pipeline efficiency depends on effective recovery of Supplementary Fig. 4 for a full description of the custom Gateway-adapted plasmids used for vector construction. Thus, completion of the mutant resource will require iterative rounds of recovery. Whether some genes are refractory to targeting will become apparent once all technical issues have been ruled out.
Discussion
Our targeting pipeline is the major contributor to the international mouse knockout programmes that aim to generate lacZ-tagged null mutations in every protein-coding gene in mouse. With the technology described here, more than 9,000 genes have been successfully targeted in C57BL/6N ES cells to date. The value of our knockout ES cell resource critically depends on the germline potential of individual targeted C57BL/6N ES cell clones. In a separate study 16 , hundreds of targeted cell lines generated in our pipeline were assessed for contribution to the germline after blastocyst injection. At least 65% of targeted clones colonized the germ line of chimaeric mice. Thus, our library of mutant C57BL/6N ES cells is robust and will support the production of mutant mice for future large-scale phenotyping programmes.
The scale of mass parallel vector construction and gene targeting described here has implications for functional genomics and proteomics in many model systems. New systematic, genome-scale programmes can now be contemplated. Using available BAC or fosmid genome resources, the high-throughput production of complex transgenes and/or targeting constructs will facilitate the generation of sophisticated, physiologically accurate, cell and animal models. For example, tagging all proteins in the mouse genome by knock-in targeting to establish a proteomic mapping programme equivalent to the highly successful yeast TAP-tagging programmes 41 is now feasible. In the coming years, it is likely that the genome engineering technologies pioneered in the mouse will be also applicable to other model systems such as the rat 42, 43 and human pluripotent stem cells 44, 45 . The capacity for fluent gene targeting also permits the systematic generation of doubly targeted ES cell lines for functional studies by conditional mutagenesis, which will serve to complement and extend RNA interference studies by providing complete genetic knockouts. Coupled with the power to differentiate ES cells into many cell types, such resources will not only provide means to gaining unique functional insights but will also reduce animal experimentation. With pioneering methodologies, we have overcome the considerable technical challenges involved in establishing the most complex and accurate high-throughput functional genomics platform yet attempted. We believe that our work raises the standards of achievement and expectation for future genome-scale programmes.
METHODS SUMMARY
Gene annotation and vector design software. Manual annotation of mouse gene structures was carried out as previously described 24 . Vector designs are based on the current release of the Ensembl and Vega databases (NCBIM37 assembly). Critical exon(s) for each target gene are identified computationally (start phase 2 end phase 5 0). Using ArrayOligoSelector 46 , our software returns a set of six 50-mer oligonucleotides at defined distances from the critical exon(s) for recombineering. 96-well recombineering and three-way Gateway reactions. BAC clones are ordered from indexed C57BL/6J libraries 27 (RP23/24), arrayed in 96-well plates and transformed with pBADgbaA 47 plasmid encoding lambda Red recombination proteins. Three rounds of recombineering are carried out serially in 96-well cultures using DNA cassettes amplified by PCR with primers containing 50-nucleotide homology to target sequences 25, 26 . After gap repair, plasmid DNA is transformed into Cre-expressing bacteria to reduce the floxed kanR cassette to a single loxP site.
Three-way Gateway reactions containing intermediate vector, attL1/attL2 targeting cassette and attL3/attL4 DTA plasmids are incubated with LR Clonase II Plus (Invitrogen), transformed into bacteria and selected on agar plates containing appropriate antibiotics and 4-chlorophenylalanine 48 . Final targeting constructs are sequence-verified across each recombineered junction, linearized with AsiSI and visualized on E-Gels (Invitrogen) to verify their size (Supplementary Fig. 5 ). Electroporation of ES cells and LR-PCR genotyping. Electroporation of C57BL/ 6N mouse ES cells 16 with linearized plasmid DNA was carried out in 25-well electroporation cuvettes (BTX Harvard Apparatus). Stable clones were selected in medium containing Geneticin (Invitrogen). Typically 32 clones are picked, expanded in 96-well plates and archived in 96-well cryovials (Matrix).
Long-range PCR reactions using SequalPrep (Life Technologies) or LongAMP (NEB) were carried out with genomic DNA from direct lysis of ES cells grown in 96-well plates. PCR products were visualized on E-gels ( Supplementary Fig. 6 ) then treated with exonuclease I and phosphatase (NEB) and sequenced. (59Us and 39Us) . To confirm the presence or absence of the 39 loxP site, 39 arm LR-PCR products are sequenced with a primer adjacent to the loxP site (LR). In cases where 39 arm LR-PCR fails to generate a product, the 39 loxP site is confirmed by sequencing the cassette product.
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